Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination

Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the etiological agent of COVID-19, has caused over 460 million cases of infection and over 6 million deaths worldwide. The pandemic has called for science, technology, and innovation to provide solutions and, due to an incredible...

Full description

Bibliographic Details
Main Authors: Giuseppina Sanna, Alessandra Marongiu, Davide Firinu, Cristina Piras, Gianluigi Franci, Massimiliano Galdiero, Giuseppe Pala, Vanessa Palmas, Fabrizio Angius, Roberto Littera, Andrea Perra, Germano Orrù, Marcello Campagna, Giulia Costanzo, Federico Meloni, Ferdinando Coghe, Luchino Chessa, Aldo Manzin
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
COVID-19
BNT162b2 vaccine
CLIA
Antibody
neutralization assay
Online Access:https://www.mdpi.com/2076-393X/10/4/531

Internet

https://www.mdpi.com/2076-393X/10/4/531

Similar Items